Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial

Peer Review reports

Original Submission
3 Aug 2020	Submitted	Original manuscript
28 Aug 2020	Reviewed	Reviewer Report - Kirsty Loudon
16 Oct 2020	Reviewed	Reviewer Report - Lee Kennedy-Shaffer
4 Dec 2020	Author responded	Author comments - Iwein Gyselinck
Resubmission - Version 2
4 Dec 2020	Submitted	Manuscript version 2
17 Dec 2020	Reviewed	Reviewer Report - Kirsty Loudon
24 Dec 2020	Reviewed	Reviewer Report - Lee Kennedy-Shaffer
6 Jan 2021	Author responded	Author comments - Iwein Gyselinck
Resubmission - Version 3
6 Jan 2021	Submitted	Manuscript version 3
Publishing
8 Jan 2021	Editorially accepted
9 Feb 2021	Article published	10.1186/s13063-021-05033-x

Back to article page